Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics

Abstract excerpt

Targeting chokepoint enzymes in metabolic pathways has led to new drugs for cancers, autoimmune disorders and infectious diseases. This is also a cornerstone approach for discovery and development of anthelmintics against nematode and flatworm parasites. Here, we performed omics-driven knowledge-based identification of chokepoint enzymes as anthelmintic targets. We prioritized 10 of 186 phylogenetically conserved...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Parasites and Host Interactions
• Share to Research on Leishmaniasis Studies
• Share to Trypanosoma species research and implications